

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 7.03475064 |
| 2 | central nervous system myelination (GO:0022010) | 7.03475064 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.17845104 |
| 4 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.73854298 |
| 5 | ensheathment of neurons (GO:0007272) | 4.53153253 |
| 6 | axon ensheathment (GO:0008366) | 4.53153253 |
| 7 | myelination (GO:0042552) | 4.46394789 |
| 8 | fatty acid elongation (GO:0030497) | 4.43046073 |
| 9 | response to peptidoglycan (GO:0032494) | 4.31066283 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.22808797 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.14730444 |
| 12 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.99802866 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.96911807 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.89698732 |
| 15 | positive regulation of antigen processing and presentation (GO:0002579) | 3.82670915 |
| 16 | L-amino acid import (GO:0043092) | 3.79888120 |
| 17 | response to lipoprotein particle (GO:0055094) | 3.78582492 |
| 18 | neutrophil activation (GO:0042119) | 3.75845201 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 3.71884993 |
| 20 | NIK/NF-kappaB signaling (GO:0038061) | 3.64731638 |
| 21 | positive regulation of B cell differentiation (GO:0045579) | 3.64467376 |
| 22 | adhesion of symbiont to host cell (GO:0044650) | 3.64030246 |
| 23 | virion attachment to host cell (GO:0019062) | 3.64030246 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.62571309 |
| 25 | regulation of antigen processing and presentation (GO:0002577) | 3.58659932 |
| 26 | amyloid precursor protein metabolic process (GO:0042982) | 3.58418349 |
| 27 | detection of other organism (GO:0098543) | 3.56163996 |
| 28 | detection of bacterium (GO:0016045) | 3.53518204 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.52096493 |
| 30 | granulocyte activation (GO:0036230) | 3.50575449 |
| 31 | respiratory burst (GO:0045730) | 3.48657965 |
| 32 | mannose metabolic process (GO:0006013) | 3.47825473 |
| 33 | oligodendrocyte differentiation (GO:0048709) | 3.47160061 |
| 34 | B cell receptor signaling pathway (GO:0050853) | 3.45311423 |
| 35 | germinal center formation (GO:0002467) | 3.41546035 |
| 36 | positive regulation of interleukin-17 production (GO:0032740) | 3.41221983 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 3.33514233 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.33514233 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.33514233 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.33514233 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.33514233 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.33514233 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.31349867 |
| 44 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.29272121 |
| 45 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.28460735 |
| 46 | amyloid precursor protein catabolic process (GO:0042987) | 3.26403270 |
| 47 | activated T cell proliferation (GO:0050798) | 3.24454087 |
| 48 | response to type I interferon (GO:0034340) | 3.20033279 |
| 49 | cellular response to type I interferon (GO:0071357) | 3.19493885 |
| 50 | type I interferon signaling pathway (GO:0060337) | 3.19493885 |
| 51 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.18798140 |
| 52 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.16867795 |
| 53 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.11269438 |
| 54 | interferon-gamma production (GO:0032609) | 3.11016787 |
| 55 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.08949600 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 3.08097389 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.07442023 |
| 58 | detection of external biotic stimulus (GO:0098581) | 3.07414471 |
| 59 | creatine metabolic process (GO:0006600) | 3.06860337 |
| 60 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.05590444 |
| 61 | Golgi to endosome transport (GO:0006895) | 3.05210289 |
| 62 | glycosylceramide metabolic process (GO:0006677) | 3.04371239 |
| 63 | myeloid cell activation involved in immune response (GO:0002275) | 3.04336324 |
| 64 | regulation of interleukin-17 production (GO:0032660) | 2.99393765 |
| 65 | negative regulation of macroautophagy (GO:0016242) | 2.97968312 |
| 66 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.97259681 |
| 67 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.96238114 |
| 68 | regulation of leukocyte degranulation (GO:0043300) | 2.95927445 |
| 69 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.94898349 |
| 70 | leukocyte degranulation (GO:0043299) | 2.92373016 |
| 71 | adhesion of symbiont to host (GO:0044406) | 2.89636436 |
| 72 | regulation of B cell differentiation (GO:0045577) | 2.87245211 |
| 73 | protein localization to endosome (GO:0036010) | 2.85891897 |
| 74 | amino sugar catabolic process (GO:0046348) | 2.84203479 |
| 75 | protein kinase C signaling (GO:0070528) | 2.83405824 |
| 76 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.83131684 |
| 77 | amino acid import (GO:0043090) | 2.82989280 |
| 78 | detection of molecule of bacterial origin (GO:0032490) | 2.82748565 |
| 79 | import into cell (GO:0098657) | 2.80571529 |
| 80 | leukocyte aggregation (GO:0070486) | 2.80136878 |
| 81 | neutrophil mediated immunity (GO:0002446) | 2.80118644 |
| 82 | barbed-end actin filament capping (GO:0051016) | 2.79919038 |
| 83 | myeloid dendritic cell differentiation (GO:0043011) | 2.78912232 |
| 84 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.77853214 |
| 85 | macrophage activation involved in immune response (GO:0002281) | 2.77150525 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76718993 |
| 87 | negative regulation of cell killing (GO:0031342) | 2.76297308 |
| 88 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.76297308 |
| 89 | positive thymic T cell selection (GO:0045059) | 2.74783558 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.74356699 |
| 91 | response to host immune response (GO:0052572) | 2.72384619 |
| 92 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.72384619 |
| 93 | regulation of neutrophil chemotaxis (GO:0090022) | 2.71168152 |
| 94 | regulation of neutrophil migration (GO:1902622) | 2.71168152 |
| 95 | response to protozoan (GO:0001562) | 2.70528409 |
| 96 | cellular extravasation (GO:0045123) | 2.70451648 |
| 97 | response to muramyl dipeptide (GO:0032495) | 2.70237077 |
| 98 | positive regulation of action potential (GO:0045760) | 2.69998495 |
| 99 | mature B cell differentiation involved in immune response (GO:0002313) | 2.68802095 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.68470684 |
| 101 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68096131 |
| 102 | detection of biotic stimulus (GO:0009595) | 2.67891950 |
| 103 | histone H3-K4 trimethylation (GO:0080182) | 2.67749179 |
| 104 | response to laminar fluid shear stress (GO:0034616) | 2.66957902 |
| 105 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.66439310 |
| 106 | negative regulation of type 2 immune response (GO:0002829) | 2.65155468 |
| 107 | regulation of collateral sprouting (GO:0048670) | 2.64492527 |
| 108 | mast cell activation (GO:0045576) | 2.63287458 |
| 109 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.62833218 |
| 110 | response to host (GO:0075136) | 2.62833218 |
| 111 | response to host defenses (GO:0052200) | 2.62833218 |
| 112 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.62243318 |
| 113 | negative regulation of B cell proliferation (GO:0030889) | 2.61678838 |
| 114 | defense response to protozoan (GO:0042832) | 2.61479811 |
| 115 | negative regulation of innate immune response (GO:0045824) | 2.60520520 |
| 116 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.60306048 |
| 117 | superoxide anion generation (GO:0042554) | 2.60076687 |
| 118 | mature B cell differentiation (GO:0002335) | 2.59783107 |
| 119 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.59400632 |
| 120 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.59247742 |
| 121 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.58776647 |
| 122 | regulation of type 2 immune response (GO:0002828) | 2.58523896 |
| 123 | heterotypic cell-cell adhesion (GO:0034113) | 2.57957558 |
| 124 | protein palmitoylation (GO:0018345) | 2.57520772 |
| 125 | B cell homeostasis (GO:0001782) | 2.57242051 |
| 126 | myeloid dendritic cell activation (GO:0001773) | 2.56786097 |
| 127 | macrophage activation (GO:0042116) | 2.56204032 |
| 128 | glycerophospholipid catabolic process (GO:0046475) | 2.53897706 |
| 129 | modulation by symbiont of host cellular process (GO:0044068) | 2.53666849 |
| 130 | pinocytosis (GO:0006907) | 2.51765930 |
| 131 | T cell migration (GO:0072678) | 2.51750036 |
| 132 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.50844390 |
| 133 | glycosphingolipid catabolic process (GO:0046479) | 2.49646986 |
| 134 | T-helper 1 type immune response (GO:0042088) | 2.48816400 |
| 135 | intracellular pH reduction (GO:0051452) | 2.48726012 |
| 136 | positive regulation of interleukin-10 production (GO:0032733) | 2.48073985 |
| 137 | positive regulation of T cell cytokine production (GO:0002726) | 2.48073175 |
| 138 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.47606228 |
| 139 | immunoglobulin mediated immune response (GO:0016064) | 2.47563291 |
| 140 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.47394521 |
| 141 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.47130294 |
| 142 | negative regulation of interleukin-6 production (GO:0032715) | 2.46737618 |
| 143 | regulation of necroptotic process (GO:0060544) | 2.45952841 |
| 144 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.45456019 |
| 145 | regulation of platelet aggregation (GO:0090330) | 2.44907862 |
| 146 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.44861641 |
| 147 | thymic T cell selection (GO:0045061) | 2.44575538 |
| 148 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.44177268 |
| 149 | regulation of activation of Janus kinase activity (GO:0010533) | 2.43113081 |
| 150 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.42934616 |
| 151 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.42450629 |
| 152 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.42062300 |
| 153 | regulation of necrotic cell death (GO:0010939) | 2.41699935 |
| 154 | regulation of interferon-alpha production (GO:0032647) | 2.41674881 |
| 155 | cellular response to virus (GO:0098586) | 2.39424494 |
| 156 | negative regulation of interleukin-1 production (GO:0032692) | 2.39043748 |
| 157 | positive regulation of interferon-alpha production (GO:0032727) | 2.38137983 |
| 158 | regulation of ARF GTPase activity (GO:0032312) | 2.37993063 |
| 159 | modulation by virus of host process (GO:0019054) | 2.37931139 |
| 160 | G-protein coupled receptor internalization (GO:0002031) | 2.37582631 |
| 161 | tolerance induction (GO:0002507) | 2.37488551 |
| 162 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.36949430 |
| 163 | cholesterol biosynthetic process (GO:0006695) | 2.36792618 |
| 164 | positive regulation of type 2 immune response (GO:0002830) | 2.36789946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 5.08313619 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.64446894 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.15154662 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.08346627 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.50079495 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.45168900 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.35363461 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.96986249 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.76256673 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.66724977 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.60791144 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58751730 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.52941051 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52549576 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.32199873 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.30531740 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.18600696 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17848033 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.12831062 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.08221080 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.06313513 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.04126382 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.02395913 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94962456 |
| 25 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93355223 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.91735607 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.88758330 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.88549816 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87500499 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.85890651 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.81421991 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.80894198 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79310429 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.79074725 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.77331216 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.74523280 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69886034 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.68692174 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.66907165 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.65538021 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.60529677 |
| 42 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.60279812 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57694530 |
| 44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.57319301 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51655501 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49648204 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.46226114 |
| 48 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45917072 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40826291 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40381633 |
| 51 | P68_20966046_ChIP-Seq_HELA_Human | 1.39991607 |
| 52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39016129 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.36992944 |
| 54 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36423432 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36354277 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36353587 |
| 57 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.35832279 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33835064 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31931177 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31421661 |
| 61 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30376057 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27900922 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26994168 |
| 64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26660199 |
| 65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25317315 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.24740838 |
| 67 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.23787710 |
| 68 | MYB_26560356_Chip-Seq_TH1_Human | 1.22775052 |
| 69 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22113655 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.21715331 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21509073 |
| 72 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21140864 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20376699 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18630660 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17468726 |
| 76 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.17404013 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16565751 |
| 78 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16151695 |
| 79 | MAF_26560356_Chip-Seq_TH2_Human | 1.15469839 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15124768 |
| 81 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15075858 |
| 82 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14367236 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14321670 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14091445 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12409577 |
| 86 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12368782 |
| 87 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12327738 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12181550 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11020692 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09811577 |
| 91 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09577459 |
| 92 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08569879 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06641327 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06244349 |
| 95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05378961 |
| 96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05297153 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04159522 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03933229 |
| 99 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03154821 |
| 100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02830375 |
| 101 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02579403 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01200214 |
| 103 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00931434 |
| 104 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.99720209 |
| 105 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99606724 |
| 106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98971812 |
| 107 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98872291 |
| 108 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98621741 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98609940 |
| 110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98320957 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97972808 |
| 112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94600360 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93954598 |
| 114 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90260067 |
| 115 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90220506 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90176333 |
| 117 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90152965 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86812028 |
| 119 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85871585 |
| 120 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82866038 |
| 121 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.82504546 |
| 122 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82175407 |
| 123 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81206357 |
| 124 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81173512 |
| 125 | SA1_27219007_Chip-Seq_Bcells_Human | 0.78754275 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.75088203 |
| 127 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.74635810 |
| 128 | KDM2B_26808549_Chip-Seq_K562_Human | 0.72527987 |
| 129 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.72512132 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.72308246 |
| 131 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.70555013 |
| 132 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.70517369 |
| 133 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.70377023 |
| 134 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.70124948 |
| 135 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69840226 |
| 136 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.69613092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 3.74579522 |
| 2 | MP0003172_abnormal_lysosome_physiology | 3.48191347 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.36737717 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.18981066 |
| 5 | MP0005387_immune_system_phenotype | 2.90846619 |
| 6 | MP0001790_abnormal_immune_system | 2.90846619 |
| 7 | MP0003690_abnormal_glial_cell | 2.57100592 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.56989447 |
| 9 | MP0006082_CNS_inflammation | 2.52439460 |
| 10 | MP0002419_abnormal_innate_immunity | 2.52434778 |
| 11 | MP0008260_abnormal_autophagy | 2.49882606 |
| 12 | MP0000685_abnormal_immune_system | 2.48717068 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.47222176 |
| 14 | MP0001800_abnormal_humoral_immune | 2.41763104 |
| 15 | MP0005671_abnormal_response_to | 2.34426934 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.32959775 |
| 17 | MP0003436_decreased_susceptibility_to | 2.26174645 |
| 18 | MP0005451_abnormal_body_composition | 2.19507599 |
| 19 | MP0005025_abnormal_response_to | 2.19046336 |
| 20 | MP0002723_abnormal_immune_serum | 2.17688719 |
| 21 | MP0004381_abnormal_hair_follicle | 2.17196110 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.14572841 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.01807902 |
| 24 | MP0009840_abnormal_foam_cell | 2.00412993 |
| 25 | MP0003136_yellow_coat_color | 1.99170397 |
| 26 | MP0005310_abnormal_salivary_gland | 1.98790295 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.98383886 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.96893301 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.94953052 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.91300589 |
| 31 | MP0001819_abnormal_immune_cell | 1.89451482 |
| 32 | MP0005075_abnormal_melanosome_morpholog | 1.87029953 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.86308328 |
| 34 | MP0009785_altered_susceptibility_to | 1.80527075 |
| 35 | MP0004510_myositis | 1.71187178 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.66243845 |
| 37 | MP0000858_altered_metastatic_potential | 1.61757092 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.61435060 |
| 39 | MP0003634_abnormal_glial_cell | 1.58180814 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.56806827 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.56806827 |
| 42 | MP0003303_peritoneal_inflammation | 1.56386859 |
| 43 | MP0000716_abnormal_immune_system | 1.55271928 |
| 44 | MP0004742_abnormal_vestibular_system | 1.48880739 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.48376416 |
| 46 | MP0001873_stomach_inflammation | 1.45481559 |
| 47 | MP0009278_abnormal_bone_marrow | 1.40603084 |
| 48 | MP0002398_abnormal_bone_marrow | 1.40210545 |
| 49 | MP0005409_darkened_coat_color | 1.34350786 |
| 50 | MP0002405_respiratory_system_inflammati | 1.33397991 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.33266686 |
| 52 | MP0000343_altered_response_to | 1.32781871 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.32356717 |
| 54 | MP0004270_analgesia | 1.31598812 |
| 55 | MP0001849_ear_inflammation | 1.31251902 |
| 56 | MP0001853_heart_inflammation | 1.30668638 |
| 57 | MP0003279_aneurysm | 1.29609787 |
| 58 | MP0003091_abnormal_cell_migration | 1.27980959 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.27070564 |
| 60 | MP0002254_reproductive_system_inflammat | 1.25005470 |
| 61 | MP0005171_absent_coat_pigmentation | 1.23014462 |
| 62 | MP0004947_skin_inflammation | 1.20705254 |
| 63 | MP0004142_abnormal_muscle_tone | 1.20411637 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.20187095 |
| 65 | MP0002722_abnormal_immune_system | 1.18117053 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.16338144 |
| 67 | MP0002429_abnormal_blood_cell | 1.16225875 |
| 68 | MP0002933_joint_inflammation | 1.14571170 |
| 69 | MP0004885_abnormal_endolymph | 1.14517505 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 1.13010718 |
| 71 | MP0003828_pulmonary_edema | 1.12437789 |
| 72 | MP0002229_neurodegeneration | 1.12143719 |
| 73 | MP0000604_amyloidosis | 1.12079829 |
| 74 | MP0003763_abnormal_thymus_physiology | 1.10994347 |
| 75 | MP0001533_abnormal_skeleton_physiology | 1.10132652 |
| 76 | MP0008057_abnormal_DNA_replication | 1.09996626 |
| 77 | MP0004858_abnormal_nervous_system | 1.09449544 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.06918230 |
| 79 | MP0001851_eye_inflammation | 1.06582001 |
| 80 | MP0008469_abnormal_protein_level | 1.06442542 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 1.06015496 |
| 82 | MP0001486_abnormal_startle_reflex | 1.05837895 |
| 83 | MP0005390_skeleton_phenotype | 1.05673335 |
| 84 | MP0002877_abnormal_melanocyte_morpholog | 1.04899222 |
| 85 | MP0003566_abnormal_cell_adhesion | 1.04735295 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 1.01688695 |
| 87 | MP0009764_decreased_sensitivity_to | 1.00925461 |
| 88 | MP0008004_abnormal_stomach_pH | 0.98541729 |
| 89 | MP0003632_abnormal_nervous_system | 0.97035152 |
| 90 | MP0003866_abnormal_defecation | 0.96698763 |
| 91 | MP0008438_abnormal_cutaneous_collagen | 0.95395054 |
| 92 | MP0005166_decreased_susceptibility_to | 0.94356009 |
| 93 | MP0000490_abnormal_crypts_of | 0.93454239 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.92315328 |
| 95 | MP0004147_increased_porphyrin_level | 0.92287232 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.90365562 |
| 97 | MP0005023_abnormal_wound_healing | 0.89759575 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.89124063 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.87544603 |
| 100 | MP0001663_abnormal_digestive_system | 0.87191702 |
| 101 | MP0001529_abnormal_vocalization | 0.87068659 |
| 102 | MP0000383_abnormal_hair_follicle | 0.86865689 |
| 103 | MP0003724_increased_susceptibility_to | 0.86575001 |
| 104 | MP0001958_emphysema | 0.86296124 |
| 105 | MP0009046_muscle_twitch | 0.85857682 |
| 106 | MP0001905_abnormal_dopamine_level | 0.85441851 |
| 107 | MP0002166_altered_tumor_susceptibility | 0.85129144 |
| 108 | MP0003045_fibrosis | 0.85120668 |
| 109 | MP0005164_abnormal_response_to | 0.81780937 |
| 110 | MP0002064_seizures | 0.81728532 |
| 111 | MP0002332_abnormal_exercise_endurance | 0.81280571 |
| 112 | MP0004808_abnormal_hematopoietic_stem | 0.80480142 |
| 113 | MP0004185_abnormal_adipocyte_glucose | 0.80244840 |
| 114 | MP0003795_abnormal_bone_structure | 0.78558529 |
| 115 | MP0009763_increased_sensitivity_to | 0.78121948 |
| 116 | MP0002132_abnormal_respiratory_system | 0.78100281 |
| 117 | MP0000767_abnormal_smooth_muscle | 0.76947051 |
| 118 | MP0000249_abnormal_blood_vessel | 0.74963298 |
| 119 | MP0002138_abnormal_hepatobiliary_system | 0.74408373 |
| 120 | MP0002272_abnormal_nervous_system | 0.74102323 |
| 121 | MP0002095_abnormal_skin_pigmentation | 0.73211005 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.73094404 |
| 123 | MP0001346_abnormal_lacrimal_gland | 0.72973348 |
| 124 | MP0003329_amyloid_beta_deposits | 0.72775835 |
| 125 | MP0004883_abnormal_blood_vessel | 0.72596604 |
| 126 | MP0000703_abnormal_thymus_morphology | 0.71286176 |
| 127 | MP0002796_impaired_skin_barrier | 0.71237430 |
| 128 | MP0005645_abnormal_hypothalamus_physiol | 0.71024141 |
| 129 | MP0002139_abnormal_hepatobiliary_system | 0.67299569 |
| 130 | MP0003448_altered_tumor_morphology | 0.66356314 |
| 131 | MP0003075_altered_response_to | 0.61807923 |
| 132 | MP0000778_abnormal_nervous_system | 0.60452252 |
| 133 | MP0008569_lethality_at_weaning | 0.56558913 |
| 134 | MP0000371_diluted_coat_color | 0.54616059 |
| 135 | MP0008874_decreased_physiological_sensi | 0.54421955 |
| 136 | MP0002998_abnormal_bone_remodeling | 0.54356950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.49455773 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.13997325 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.03172009 |
| 4 | Neurofibrillary tangles (HP:0002185) | 3.97585293 |
| 5 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.93756909 |
| 6 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.93756909 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.90040100 |
| 8 | Recurrent skin infections (HP:0001581) | 3.82227633 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 3.68430468 |
| 10 | Optic neuritis (HP:0100653) | 3.68430468 |
| 11 | Parakeratosis (HP:0001036) | 3.61166798 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.60436811 |
| 13 | Recurrent cutaneous fungal infections (HP:0011370) | 3.60436811 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.52976222 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.51934497 |
| 16 | Stomatitis (HP:0010280) | 3.38852012 |
| 17 | Myositis (HP:0100614) | 3.37990692 |
| 18 | Orchitis (HP:0100796) | 3.29411300 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.28925231 |
| 20 | Abnormality of glycolipid metabolism (HP:0010969) | 3.28925231 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.28925231 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.27159350 |
| 23 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.14892709 |
| 24 | Loss of speech (HP:0002371) | 3.01935982 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.00898166 |
| 26 | Slow saccadic eye movements (HP:0000514) | 2.99105564 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 2.98162322 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 2.96640813 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.94331146 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.93586437 |
| 31 | Abnormality of the corticospinal tract (HP:0002492) | 2.91000348 |
| 32 | Onion bulb formation (HP:0003383) | 2.90678143 |
| 33 | Chronic otitis media (HP:0000389) | 2.85386595 |
| 34 | Akinesia (HP:0002304) | 2.81155618 |
| 35 | Hepatosplenomegaly (HP:0001433) | 2.80381285 |
| 36 | Vasculitis (HP:0002633) | 2.76906367 |
| 37 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.72999482 |
| 38 | Mucopolysacchariduria (HP:0008155) | 2.72999482 |
| 39 | Sensory axonal neuropathy (HP:0003390) | 2.72126990 |
| 40 | Duplicated collecting system (HP:0000081) | 2.68362256 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66703719 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.65052765 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.64813217 |
| 44 | Recurrent viral infections (HP:0004429) | 2.61551408 |
| 45 | Meningitis (HP:0001287) | 2.59128884 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.58048493 |
| 47 | Vertebral compression fractures (HP:0002953) | 2.55799971 |
| 48 | Gingival bleeding (HP:0000225) | 2.52998317 |
| 49 | Gingivitis (HP:0000230) | 2.51727920 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.50191496 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.48417132 |
| 52 | Obstructive lung disease (HP:0006536) | 2.48417132 |
| 53 | Gastrointestinal stroma tumor (HP:0100723) | 2.47704843 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.42910951 |
| 55 | Increased serum ferritin (HP:0003281) | 2.41861237 |
| 56 | J-shaped sella turcica (HP:0002680) | 2.38873433 |
| 57 | Cerebral aneurysm (HP:0004944) | 2.38087902 |
| 58 | Pulmonary infiltrates (HP:0002113) | 2.37467438 |
| 59 | Nuclear cataract (HP:0100018) | 2.37227583 |
| 60 | Colitis (HP:0002583) | 2.35984418 |
| 61 | Petechiae (HP:0000967) | 2.34806707 |
| 62 | Cellulitis (HP:0100658) | 2.32328909 |
| 63 | Interstitial pulmonary disease (HP:0006530) | 2.31823227 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.27555550 |
| 65 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.27452337 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.26399706 |
| 67 | Pustule (HP:0200039) | 2.24979080 |
| 68 | Prolonged neonatal jaundice (HP:0006579) | 2.23754624 |
| 69 | Abnormality of the renal collecting system (HP:0004742) | 2.23153669 |
| 70 | Recurrent pneumonia (HP:0006532) | 2.22378043 |
| 71 | Axonal loss (HP:0003447) | 2.20953328 |
| 72 | Cheilitis (HP:0100825) | 2.19042443 |
| 73 | Broad face (HP:0000283) | 2.18816497 |
| 74 | Thoracic kyphosis (HP:0002942) | 2.18020349 |
| 75 | Gastrointestinal infarctions (HP:0005244) | 2.16620623 |
| 76 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.16323111 |
| 77 | Osteomyelitis (HP:0002754) | 2.15057438 |
| 78 | Leukocytosis (HP:0001974) | 2.12348521 |
| 79 | White forelock (HP:0002211) | 2.12010509 |
| 80 | Increased IgE level (HP:0003212) | 2.11945749 |
| 81 | Malnutrition (HP:0004395) | 2.11405276 |
| 82 | Emphysema (HP:0002097) | 2.11076317 |
| 83 | Thin bony cortex (HP:0002753) | 2.10845753 |
| 84 | Premature skin wrinkling (HP:0100678) | 2.09841988 |
| 85 | * Spastic gait (HP:0002064) | 2.07588562 |
| 86 | Urticaria (HP:0001025) | 2.05122532 |
| 87 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03799400 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03799400 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03799400 |
| 90 | Eosinophilia (HP:0001880) | 2.02973919 |
| 91 | Mediastinal lymphadenopathy (HP:0100721) | 2.02770396 |
| 92 | Purpura (HP:0000979) | 2.01808178 |
| 93 | Stridor (HP:0010307) | 2.01638608 |
| 94 | Hemorrhage of the eye (HP:0011885) | 2.01262575 |
| 95 | T lymphocytopenia (HP:0005403) | 2.00933887 |
| 96 | Encephalitis (HP:0002383) | 2.00838440 |
| 97 | Cervical subluxation (HP:0003308) | 2.00421981 |
| 98 | Amyloidosis (HP:0011034) | 1.99837847 |
| 99 | Peripheral demyelination (HP:0011096) | 1.99669163 |
| 100 | Neuronal loss in central nervous system (HP:0002529) | 1.97033332 |
| 101 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.95588477 |
| 102 | Depressed nasal tip (HP:0000437) | 1.95243596 |
| 103 | Autoimmune thrombocytopenia (HP:0001973) | 1.95097028 |
| 104 | Polygenic inheritance (HP:0010982) | 1.94789812 |
| 105 | Distal lower limb amyotrophy (HP:0008944) | 1.94682438 |
| 106 | Hemoptysis (HP:0002105) | 1.93761163 |
| 107 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93738942 |
| 108 | Upper motor neuron abnormality (HP:0002127) | 1.93317611 |
| 109 | Abnormality of the nasal mucosa (HP:0000433) | 1.92985830 |
| 110 | Progressive neurologic deterioration (HP:0002344) | 1.90132231 |
| 111 | Abnormality of the thoracic spine (HP:0100711) | 1.88413841 |
| 112 | Hypergammaglobulinemia (HP:0010702) | 1.88236566 |
| 113 | Leukopenia (HP:0001882) | 1.87339303 |
| 114 | Achilles tendon contracture (HP:0001771) | 1.87300440 |
| 115 | Restrictive lung disease (HP:0002091) | 1.86305975 |
| 116 | Abnormality of T cell number (HP:0011839) | 1.86106879 |
| 117 | Chromsome breakage (HP:0040012) | 1.85604279 |
| 118 | Peripheral hypomyelination (HP:0007182) | 1.85520532 |
| 119 | Abnormality of eosinophils (HP:0001879) | 1.84987413 |
| 120 | Albinism (HP:0001022) | 1.84435848 |
| 121 | Bone pain (HP:0002653) | 1.83845732 |
| 122 | Increased IgM level (HP:0003496) | 1.83738621 |
| 123 | Hypertensive crisis (HP:0100735) | 1.83465008 |
| 124 | Myocardial infarction (HP:0001658) | 1.82238767 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.82122506 |
| 126 | Spondylolisthesis (HP:0003302) | 1.81987324 |
| 127 | Epistaxis (HP:0000421) | 1.81191935 |
| 128 | Joint stiffness (HP:0001387) | 1.81127288 |
| 129 | Keratoconjunctivitis sicca (HP:0001097) | 1.80603148 |
| 130 | Abnormality of the fingertips (HP:0001211) | 1.80091867 |
| 131 | Hyperacusis (HP:0010780) | 1.79997114 |
| 132 | Increased connective tissue (HP:0009025) | 1.79803031 |
| 133 | Erythroderma (HP:0001019) | 1.79545026 |
| 134 | Submucous cleft hard palate (HP:0000176) | 1.78930327 |
| 135 | Ocular albinism (HP:0001107) | 1.78584118 |
| 136 | Distal lower limb muscle weakness (HP:0009053) | 1.78261281 |
| 137 | Disinhibition (HP:0000734) | 1.77716209 |
| 138 | Hypertriglyceridemia (HP:0002155) | 1.77640691 |
| 139 | Spastic tetraparesis (HP:0001285) | 1.77493098 |
| 140 | Prolonged bleeding time (HP:0003010) | 1.77052841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB1 | 4.74786693 |
| 2 | MAP4K1 | 3.27644322 |
| 3 | TRIB3 | 3.23013447 |
| 4 | STK39 | 3.07814419 |
| 5 | IRAK4 | 2.48303668 |
| 6 | SIK1 | 2.43554067 |
| 7 | MAP2K3 | 2.28551931 |
| 8 | MAP3K11 | 2.26778052 |
| 9 | ERN1 | 2.25931831 |
| 10 | OXSR1 | 2.25131633 |
| 11 | MAP3K13 | 2.19219792 |
| 12 | BLK | 2.17418507 |
| 13 | IRAK3 | 2.15969166 |
| 14 | CLK1 | 2.13123620 |
| 15 | NME2 | 2.09679840 |
| 16 | SMG1 | 2.08744477 |
| 17 | MAP3K14 | 2.07856712 |
| 18 | PKN1 | 2.04891534 |
| 19 | TNIK | 1.92848066 |
| 20 | ICK | 1.92545398 |
| 21 | IKBKE | 1.89464110 |
| 22 | TAOK2 | 1.86153846 |
| 23 | TYK2 | 1.86108241 |
| 24 | SIK2 | 1.83052881 |
| 25 | TAOK3 | 1.78797517 |
| 26 | KIT | 1.77838274 |
| 27 | TAOK1 | 1.74173710 |
| 28 | MAP3K3 | 1.72823188 |
| 29 | TESK2 | 1.70681946 |
| 30 | FES | 1.70150352 |
| 31 | RIPK1 | 1.60542784 |
| 32 | IKBKB | 1.60286489 |
| 33 | BTK | 1.55257768 |
| 34 | PRPF4B | 1.49909340 |
| 35 | RIPK4 | 1.42658099 |
| 36 | EPHA3 | 1.40279708 |
| 37 | IRAK1 | 1.37635938 |
| 38 | CSK | 1.36749521 |
| 39 | HCK | 1.36587467 |
| 40 | TBK1 | 1.36458219 |
| 41 | CSF1R | 1.36429040 |
| 42 | SIK3 | 1.35355835 |
| 43 | PRKD2 | 1.34045688 |
| 44 | JAK1 | 1.32762394 |
| 45 | CDC42BPA | 1.28322429 |
| 46 | TXK | 1.27462924 |
| 47 | MAP3K1 | 1.26443494 |
| 48 | CDK12 | 1.21776752 |
| 49 | CDK19 | 1.21699118 |
| 50 | TESK1 | 1.21060337 |
| 51 | LCK | 1.13040668 |
| 52 | DDR2 | 1.10163643 |
| 53 | ITK | 1.08858317 |
| 54 | FGR | 1.05787119 |
| 55 | CSNK1A1L | 1.02990209 |
| 56 | ADRBK2 | 1.02902694 |
| 57 | TGFBR2 | 1.01386943 |
| 58 | SYK | 0.97776210 |
| 59 | BRD4 | 0.97633325 |
| 60 | FGFR4 | 0.97411509 |
| 61 | TTN | 0.97364411 |
| 62 | YES1 | 0.95942948 |
| 63 | WNK1 | 0.94788299 |
| 64 | MARK2 | 0.90035211 |
| 65 | PIM2 | 0.89600160 |
| 66 | PKN2 | 0.88616426 |
| 67 | MAPK15 | 0.88506078 |
| 68 | PRKCQ | 0.88279623 |
| 69 | RPS6KL1 | 0.83518104 |
| 70 | RPS6KC1 | 0.83518104 |
| 71 | LYN | 0.81971646 |
| 72 | NEK6 | 0.81856919 |
| 73 | RPS6KA2 | 0.81573359 |
| 74 | CSNK1G3 | 0.81003969 |
| 75 | UHMK1 | 0.80104723 |
| 76 | MAP3K6 | 0.78867108 |
| 77 | ZAP70 | 0.78390750 |
| 78 | PAK4 | 0.78056029 |
| 79 | WNK4 | 0.77970864 |
| 80 | BCR | 0.77580305 |
| 81 | TRPM7 | 0.73641943 |
| 82 | IRAK2 | 0.72008873 |
| 83 | PBK | 0.71548244 |
| 84 | GRK7 | 0.70435269 |
| 85 | MET | 0.70261888 |
| 86 | MARK3 | 0.69997224 |
| 87 | PDGFRA | 0.69079491 |
| 88 | CAMK1G | 0.66663624 |
| 89 | RPS6KA6 | 0.66015902 |
| 90 | BMX | 0.65046076 |
| 91 | DYRK1B | 0.64764943 |
| 92 | BMPR2 | 0.63500915 |
| 93 | ABL2 | 0.62642631 |
| 94 | MAP3K10 | 0.61565207 |
| 95 | JAK3 | 0.61160904 |
| 96 | KDR | 0.60174116 |
| 97 | MAPK7 | 0.59621062 |
| 98 | SGK223 | 0.59375504 |
| 99 | SGK494 | 0.59375504 |
| 100 | TLK1 | 0.58595642 |
| 101 | FYN | 0.58494772 |
| 102 | TNK2 | 0.58325509 |
| 103 | PAK6 | 0.57596008 |
| 104 | KSR2 | 0.56758670 |
| 105 | MAPK11 | 0.56128276 |
| 106 | STK10 | 0.55941273 |
| 107 | PIK3CG | 0.55300980 |
| 108 | JAK2 | 0.55197763 |
| 109 | CSNK1G1 | 0.55142256 |
| 110 | ARAF | 0.55103964 |
| 111 | ABL1 | 0.54456329 |
| 112 | TEC | 0.53656922 |
| 113 | MTOR | 0.52965960 |
| 114 | MAP2K2 | 0.52787329 |
| 115 | PRKD1 | 0.52728551 |
| 116 | MAPK12 | 0.52633474 |
| 117 | CHUK | 0.50945490 |
| 118 | MOS | 0.50888372 |
| 119 | PDPK1 | 0.50586241 |
| 120 | PDK1 | 0.49786767 |
| 121 | CSNK1G2 | 0.47939624 |
| 122 | PIM1 | 0.46658900 |
| 123 | EPHA2 | 0.44930672 |
| 124 | STK4 | 0.44582854 |
| 125 | CAMK1D | 0.44435117 |
| 126 | MAPK4 | 0.43641067 |
| 127 | PRKG2 | 0.43582258 |
| 128 | STK11 | 0.43496465 |
| 129 | CDK4 | 0.43316091 |
| 130 | CDK6 | 0.42551113 |
| 131 | EEF2K | 0.42209990 |
| 132 | HIPK2 | 0.41781404 |
| 133 | CSNK1D | 0.41469522 |
| 134 | MAPKAPK5 | 0.40951669 |
| 135 | GRK6 | 0.40899686 |
| 136 | STK38 | 0.40219103 |
| 137 | MAPKAPK2 | 0.40058793 |
| 138 | ROCK2 | 0.39814825 |
| 139 | MAP2K6 | 0.39779455 |
| 140 | MAP3K8 | 0.38998647 |
| 141 | EIF2AK2 | 0.38973711 |
| 142 | MAP3K7 | 0.38737952 |
| 143 | CAMK2D | 0.37524359 |
| 144 | PTK6 | 0.35142221 |
| 145 | PRKCH | 0.34759630 |
| 146 | ALK | 0.33313282 |
| 147 | MATK | 0.32136825 |
| 148 | CDK5 | 0.31786535 |
| 149 | GSK3A | 0.31357543 |
| 150 | NLK | 0.31041145 |
| 151 | RPS6KA5 | 0.29826725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.37491322 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.08868189 |
| 3 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.58639157 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.54372574 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.48555449 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46399722 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.25997933 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.22296658 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.15774121 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.93998492 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92536312 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.89869565 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.86912374 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76505729 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75672415 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74952620 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.74698970 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.72060355 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71617711 |
| 20 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.70670127 |
| 21 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.67014283 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66460547 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60720254 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.50411970 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.50238928 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.50176357 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48786992 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.43046514 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40275252 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.32287096 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.30752069 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29832776 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.29532042 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28965843 |
| 35 | Bladder cancer_Homo sapiens_hsa05219 | 1.28229778 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.28168733 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27707167 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.25712640 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.23267750 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.22371420 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20070332 |
| 42 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.19794023 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18425853 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.17576730 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.15757313 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07521304 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06892215 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06317177 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04672202 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00978592 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00858900 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.99700228 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97188271 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96668431 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.96380778 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.96316950 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94676427 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94036028 |
| 59 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93543542 |
| 60 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92358214 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.91810876 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90488289 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.89523619 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.87677274 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87180184 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86299190 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85910318 |
| 68 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.85776851 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85077917 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.84727682 |
| 71 | Axon guidance_Homo sapiens_hsa04360 | 0.83322695 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.82943776 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80388054 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79694824 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77906455 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.75427357 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75115898 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74653740 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73450661 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72046956 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71680576 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71078712 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.70474171 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69610376 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.69363950 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66465407 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66261702 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65990652 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65596706 |
| 90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65569889 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64928258 |
| 92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64526635 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.64490029 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63990344 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63618498 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63565823 |
| 97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63347058 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61704276 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.61655053 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60693616 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60056996 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59924166 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56712355 |
| 104 | Homologous recombination_Homo sapiens_hsa03440 | 0.54701034 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54289312 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54009282 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53619500 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52476432 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52431775 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52267917 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52173566 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.52150052 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51852332 |
| 114 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51700817 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51599214 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.51313118 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50204010 |
| 118 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48680357 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47922939 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46198610 |
| 121 | Glioma_Homo sapiens_hsa05214 | 0.45701561 |
| 122 | Prostate cancer_Homo sapiens_hsa05215 | 0.44084240 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44006504 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42894647 |
| 125 | Morphine addiction_Homo sapiens_hsa05032 | 0.42464952 |
| 126 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42269673 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42258463 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41654389 |
| 129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40444391 |
| 130 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39971725 |
| 131 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39072841 |
| 132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38234979 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38169610 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38025292 |
| 135 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36221156 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36070217 |
| 137 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35114815 |
| 138 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34979322 |
| 139 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33625363 |

